These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9932659)

  • 1. A previously undescribed side effect of icodextrin: overestimation of glycemia by glucose analyzer.
    Wens R; Taminne M; Devriendt J; Collart F; Broeders N; Mestrez F; Germanos H; Dratwa M
    Perit Dial Int; 1998; 18(6):603-9. PubMed ID: 9932659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The danger of using inappropriate point-of-care glucose meters in patients on icodextrin dialysis.
    Perera NJ; Stewart PM; Williams PF; Chua EL; Yue DK; Twigg SM
    Diabet Med; 2011 Oct; 28(10):1272-6. PubMed ID: 21679233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [False measurement of glucose during dialysis with icodextrin].
    Husøy AM; Knudsen GR; Thierley M; Svarstad E
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2268-70. PubMed ID: 16967067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inaccurate self-monitoring of blood glucose readings in patients on chronic ambulatory peritoneal dialysis with icodextrin.
    Pavlicek V; Garzoni D; Urech P; Brändle M
    Exp Clin Endocrinol Diabetes; 2006 Mar; 114(3):124-6. PubMed ID: 16636978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False elevation of blood glucose levels measured by GDH-PQQ-based glucometers occurs during all daily dwells in peritoneal dialysis patients using icodextrin.
    Tsai CY; Lee SC; Hung CC; Lee JJ; Kuo MC; Hwang SJ; Chen HC
    Perit Dial Int; 2010; 30(3):329-35. PubMed ID: 20190030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease.
    Oyibo SO; Pritchard GM; McLay L; James E; Laing I; Gokal R; Boulton AJ
    Diabet Med; 2002 Aug; 19(8):693-6. PubMed ID: 12147153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falsely Elevated Glucose Concentrations in Peritoneal Dialysis Patients Using Icodextrin.
    Dogan K; Kayalp D; Ceylan G; Azak A; Senes M; Duranay M; Yucel D
    J Clin Lab Anal; 2016 Sep; 30(5):506-9. PubMed ID: 26511081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effects of a peritoneal dialysis regimen low in glucose in new peritoneal dialysis patients: a randomized crossover study.
    le Poole CY; van Ittersum FJ; Weijmer MC; Valentijn RM; ter Wee PM
    Adv Perit Dial; 2004; 20():170-6. PubMed ID: 15384821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icodextrine and insulin resistance in continuous ambulatory peritoneal dialysis patients.
    Canbakan M; Sahin GM
    Ren Fail; 2007; 29(3):289-93. PubMed ID: 17497442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe peritoneal mononucleosis associated with icodextrin use in continuous ambulatory peritoneal dialysis.
    Martín J; Sansone G; Cirugeda A; Sánchez-Tomero JA; Muñoz C; Selgas R
    Adv Perit Dial; 2003; 19():191-4. PubMed ID: 14763060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical interferences in point-of-care testing glucometers by icodextrin and its metabolites: an overview.
    Floré KM; Delanghe JR
    Perit Dial Int; 2009; 29(4):377-83. PubMed ID: 19602602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe cutaneous hypersensitivity to icodextrin in a continuous ambulatory peritoneal dialysis patient.
    Lee SH; Park HC; Sim SR; Chung SJ; Kim KJ; Park WI; Hong SW; Ha SK
    J Nephrol; 2006; 19(5):673-6. PubMed ID: 17136700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
    Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
    Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with icodextrin. Multicenter study].
    Guerrero A; Montes R; Martín-Herrera C; Ruiz A; Remón C; Fernández-Ruiz EJ; Pérez-Bañasco V; Benítez M; Martínez-Benavides E; Martínez-González JM; Torán D; Tejuca F; Páez C; del Pino MD
    Nefrologia; 2001; 21(6):574-80. PubMed ID: 11881427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icodextrin hypersensitivity in a CAPD patient.
    Lam-Po-Tang MK; Bending MR; Kwan JT
    Perit Dial Int; 1997; 17(1):82-4. PubMed ID: 9068028
    [No Abstract]   [Full Text] [Related]  

  • 16. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icodextrin-associated peritonitis among CAPD patients.
    Seow YY; Iles-Smith H; Hirst H; Gokal R
    Nephrol Dial Transplant; 2003 Sep; 18(9):1951-2. PubMed ID: 12937264
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of Glucocard Memory 2 and Accutrend sensor blood glucose meters.
    Arens S; Moons V; Meuleman P; Struyf F; Zaman Z
    Clin Chem Lab Med; 1998 Jan; 36(1):47-52. PubMed ID: 9594086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Dialysis.
    Gokal R; Mistry CD; Peers EM
    Perit Dial Int; 1995; 15(6):226-30. PubMed ID: 7578498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients.
    Amici G; Orrasch M; Da Rin G; Bocci C
    Adv Perit Dial; 2001; 17():80-3. PubMed ID: 11510303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.